Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | AORT Artivion, Inc. | ABBV AbbVie |
|---|---|---|
| Price | $23.35 -2.2% | $263.96 -0.0% |
| StockIQ Score | 48D+ Moderate Risk: Medium | 59C Moderate Risk: High |
| Technical | 23F | 88A |
| Fundamental | 54C- | 57C |
| Growth | 65B- | 34F |
| Fair Value | 33F | 33F |
| News | 86A | 100A+ |
| Quality | 63C+ | 42D |
| Risk | 46D+ | 36F |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
AORT scores higher on growth (65) while ABBV leads in investor confidence (59 vs 48), technical analysis (88 vs 23), and fundamentals (57 vs 54). Both share a MODERATE rating and identical valuation scores (33). Overall ABBV shows stronger investor and technical/fundamental metrics, whereas AORT stands out for its growth potential.
